AtriCure, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $534.5 | $465.3 | $399.2 | $330.4 | $274.3 |
| Operating income | -$9.4 | -$40.0 | -$26.7 | -$42.7 | $55.2 |
| Net income | -$11.4 | -$44.7 | -$30.4 | -$46.5 | $50.2 |
| Cash Flow Statement | |||||
| Free cash flow | $48.3 | $0.7 | -$7.5 | -$39.0 | -$23.5 |
Shares outstanding 50.9M · Free float 83.4%
Annual filing data through FY ended December 31, 2025; float as of September 27, 2026.